Treatment Registry
TR-0013 ActiveRecorded August 31, 2026Last verified September 2, 2026

Compounded semaglutide

Sold by Gala Health · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$179

Medication · 12-month plan, 48-week supply$179

Added from the figures recorded below.

Price

TermPer monthCharged today
12-month plan, 48-week supplyAdvertised

$179/mo all doses, no hidden fees

source, read September 1, 2026

Per month$179Charged today$179
Enroll with Gala Health

This is a paid link. If you enroll through it, Treatment Registry may earn a commission. It does not change what we record, and it does not change the price you pay.

History

One reading so far. A price history appears here after the next verification pass.

  • August 31, 2026Entry added to the register

Sourcing and terms

PharmacyNot disclosed as of August 31, 2026
StatesAll 50 states
PrescriberBoth
Consult feeNot disclosed as of August 31, 2026

Not yet checked: cancellation and membership.

Recorded from galaglp1.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. August 31, 2026Prices read August 2026 by completing Gala's own intake with dummy data and stopping at the plan screen, before any payment details. The public marketing page shows only $179 a month.
  2. 2. August 31, 2026The plan screen runs a countdown: "Only 24 discounts left" and "Yours is reserved for 9:57 min", above a "First shipment $120 OFF" banner. Those mechanics do not appear on any public page.
  3. 3. September 3, 2026Gala prints one figure for this plan — "$179/month. All doses included. Yearly subscription." — and never says what a card is charged on the first day. The register shows $179, the number Gala publishes, rather than the $2,148 a twelve-month commitment multiplies out to.

1 further note concerns other Gala Health programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0013
Readings
2

Related records

What else Gala Health sells

All Gala Health programs and terms

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 298 records of the same molecule.

Side by side

Cite this entry

Treatment Registry. (2026). Gala Health compounded semaglutide (TR-0013). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0013

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.